Letter to Editor
BibTex RIS Cite

Pandemic (H1N1) influenza in Diyarbakir, 2009

Year 2011, Volume: 9 Issue: 2, 86 - 95, 20.09.2011

Abstract

 

Objective: This study was conducted to evaluate the pandemic (H1N1) influenza outbreak in 2009. Method: Influenza like illness (ILI) cases were reported between the 36th to 53rd weeks of the pandemic, from all health centres. 731 nasopharyngeal swabs were collected from ILI cases. Results: The first H1N1 confirmed case was reported at the 36th week and an increasing trend continued. At the 43rd week the outbreak reached its maximum level and at the 53rd week the level had decreased to the level at the start. During the outbreak 31117 cases were reported as ILI and 635 cases were hospitalized (hospitalization rate was 2.0%) and 17 H1N1 laboratory confirmed cases died (mortality rate 11.5/1.000.000). Symptoms of laboratory confirmed cases were similar to seasonal influenza. Coughing (90.9%), fever (84.5%), running nose (69.5%), headache (73.4%), diarrhoea (17.5%) were the some of the symptoms in laboratory confirmed cases. The median interval between the onset of symptoms and hospital admission was 3.5 days (min: 1, max: 11 days) and this was 7.5 days for the occurrence of death. Conclusion: During 36th to 53rd week an important outbreak of ILI was occurred. The mortality rate was not so high as expected but the infectivity was high. The delay for hospital admission may lead to higher mortality particularly for pregnant women.

References

  • Pandemic (H1N1) 2009 - update 81, (2009)
  • http://www.who.int/csr/don/2009_12_30/ en/index.html (accessed: 30.12.2009)
  • Grip, Turkish Ministry of Health, Dec.2009. http://www.grip.gov.tr/(accessed: 30.12.2009)
  • Main surveillance developments in week 51/2009 (from 14 Dec 2009 to 20 Dec 2009) ECDC, (2009).
  • http://ecdc.europa.eu/en/publications/Pub lications/091224_EISN_Weekly_Influenz a_Surveillance_Overview.pdf (accessed: 04.01.2010) 4. Epicurve, 2009
  • http://www.ecdc.europa.eu/en/healthtopic s/PublishingImages/EU_Epicurve.JPG (Accessed: 05.01.2010)
  • European Centre for Disease prevention and control 2009. Pandemic H1N1 2009 Risk Assesment Update-30 Dec 2009
  • Echevarria-Zuno S, Mejia-Arangure JM, Mar-Obeso Roboles-Perez E, Gonzalez-Leon M, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; Nov 11 epub ahead of print. C,
  • Luan-Yin Chang, Shin-Ru Shih, Pei-Lan Shao,Daniel Tsung-Ning Huang, Li-Min Huang. Novel Swine-origin Influenza Virus A (H1N1): The First Pandemic of the 21st Century. J Formos Med Assoc 2009; 108(7): 526-32.
  • Advice to businesses on helping minimise the spread of swine flu. Cabinet office UK, (2009). http://www.cabinetoffice.gov.uk/media /225195/20090716- planningassumptions.pdf (accessed : 24.12.2009)
  • Baker MG, Wilson N, Huang QS, Paine S, Lopez L, Bandaranayake D, et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009; 14(34):pii=19319.
  • Gilsdorf A, Poggensee G. On behalf of the working group pandemic influenza A(H1N1)v Influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill 2009; 14(34):pii=19318.
  • Nishiura H, Chowell G. Rurality and pandemic heterogeneity in the risks of infection and death in Kanagawa, Japan (1918- 1919) N Z Med J 2008; 121(1284):18-27.
  • Gianella A, Walter A, Revollo R, Loayza R, Vargas J, Roca Y. Epidemiological analysis of the influenza A(H1N1) outbreak in Bolivia, May-August 2009. Euro Surveill 2009; 14(35):pii=19323.
  • Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza California. JAMA 2009; 302(17):1896- 902. infection in
  • Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009;361(26):2507-17.
  • Donaldson LJ, Rutter PD, Ellis BM, Greaves FEC, Mytton OT, Pebody RG, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009; 339: b5213 doi:10.1136/bmj.b5213 page: 1-8
  • Ofner-Agostini M, Wallington T, Henry B, Low D, McDonald LC, Berger L, et al. The SARS Investigative Team and T. Wong. Investigation of the second wave (phase 2) of severe acute respiratory syndrome (SARS) in Toronto, Canada. What happened? Disease Report 2008; 34 (2):1-11. Communicable
  • Bueving HJ, Van der Wouden JC, Berger MY and Thomas S. Incidence of influenza and associated illness in children aged 0– 19 years: a systematic review. Reviews in Medical Virology 2005; 15:383–391

Diyarbakır’da pandemik (H1N1) influenza, 2009

Year 2011, Volume: 9 Issue: 2, 86 - 95, 20.09.2011

Abstract

Amaç: Bu çalışmada 2009 yılında -Türkiye’de pandemik influenza salgınını değerlendirmek amaçlanmıştır. Yöntem: Diyarbakır ’da 36 ve 53. haftalar arasında tüm sağlık kuruluşlarından influenza benzeri hastalık rapor edilmiştir. 731 nazofaringeal sürüntü alınmıştır. Bulgular: İlk H1N1 doğrulanmış vaka 36.haftada rapor edilmiştir ve vaka sayıları zaman içinde artış göstermiştir. 43. haftada salgın başlamış ve 53. haftada başlangıç düzeyine inmiştir. Salgın sırasında 31117 vaka grip benzeri hastalık olarak raporlanmış, 635 vaka hastaneye yatmış (hastaneye yatış hızı %2.0) ve laboratuvar olarak doğrulanmış 17 vaka ölmüştür (ölüm hızı milyonda 11.5). Laboratuvar olarak doğrulanmış vakaların semptomları mevsimsel influenza ile benzerlik göstermiştir. Laboratuvar olarak doğrulanmış vakaların bazı semptomları öksürük (%90.9), ateş (%84.5), burun akıntısı (%69.5), baş ağrısı (%73.4) ve ishal (%17.5) olmuştur. Semptomların başlaması ile hastaneye başvuru suresi ortancası 3.5 gün (en az:1, en çok:11 gün), ölüm süresi ortancası ise 7.5 gündür. Sonuç: Diyarbakır’da 36 ve 53. haftalar arasında önemli bir grip benzeri hastalık salgını yaşanmıştır. Mortalite hızı beklenildiği kadar fazla olmamakla birlikte, bulaştırıcılık hızı yüksektir. Hastane başvurularındaki gecikme özellikle gebe kadınlarda ölüme yol açmış olabilir

References

  • Pandemic (H1N1) 2009 - update 81, (2009)
  • http://www.who.int/csr/don/2009_12_30/ en/index.html (accessed: 30.12.2009)
  • Grip, Turkish Ministry of Health, Dec.2009. http://www.grip.gov.tr/(accessed: 30.12.2009)
  • Main surveillance developments in week 51/2009 (from 14 Dec 2009 to 20 Dec 2009) ECDC, (2009).
  • http://ecdc.europa.eu/en/publications/Pub lications/091224_EISN_Weekly_Influenz a_Surveillance_Overview.pdf (accessed: 04.01.2010) 4. Epicurve, 2009
  • http://www.ecdc.europa.eu/en/healthtopic s/PublishingImages/EU_Epicurve.JPG (Accessed: 05.01.2010)
  • European Centre for Disease prevention and control 2009. Pandemic H1N1 2009 Risk Assesment Update-30 Dec 2009
  • Echevarria-Zuno S, Mejia-Arangure JM, Mar-Obeso Roboles-Perez E, Gonzalez-Leon M, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; Nov 11 epub ahead of print. C,
  • Luan-Yin Chang, Shin-Ru Shih, Pei-Lan Shao,Daniel Tsung-Ning Huang, Li-Min Huang. Novel Swine-origin Influenza Virus A (H1N1): The First Pandemic of the 21st Century. J Formos Med Assoc 2009; 108(7): 526-32.
  • Advice to businesses on helping minimise the spread of swine flu. Cabinet office UK, (2009). http://www.cabinetoffice.gov.uk/media /225195/20090716- planningassumptions.pdf (accessed : 24.12.2009)
  • Baker MG, Wilson N, Huang QS, Paine S, Lopez L, Bandaranayake D, et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009; 14(34):pii=19319.
  • Gilsdorf A, Poggensee G. On behalf of the working group pandemic influenza A(H1N1)v Influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill 2009; 14(34):pii=19318.
  • Nishiura H, Chowell G. Rurality and pandemic heterogeneity in the risks of infection and death in Kanagawa, Japan (1918- 1919) N Z Med J 2008; 121(1284):18-27.
  • Gianella A, Walter A, Revollo R, Loayza R, Vargas J, Roca Y. Epidemiological analysis of the influenza A(H1N1) outbreak in Bolivia, May-August 2009. Euro Surveill 2009; 14(35):pii=19323.
  • Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza California. JAMA 2009; 302(17):1896- 902. infection in
  • Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009;361(26):2507-17.
  • Donaldson LJ, Rutter PD, Ellis BM, Greaves FEC, Mytton OT, Pebody RG, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009; 339: b5213 doi:10.1136/bmj.b5213 page: 1-8
  • Ofner-Agostini M, Wallington T, Henry B, Low D, McDonald LC, Berger L, et al. The SARS Investigative Team and T. Wong. Investigation of the second wave (phase 2) of severe acute respiratory syndrome (SARS) in Toronto, Canada. What happened? Disease Report 2008; 34 (2):1-11. Communicable
  • Bueving HJ, Van der Wouden JC, Berger MY and Thomas S. Incidence of influenza and associated illness in children aged 0– 19 years: a systematic review. Reviews in Medical Virology 2005; 15:383–391
There are 19 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Original Research
Authors

Meliksah Ertem

Funda Sevencan

Vedat Dorman This is me

Neval Ozcullu This is me

Vahit Ormanli This is me

Namik Kubat This is me

Nurhan Albayrak This is me

Basak Altas This is me

Publication Date September 20, 2011
Submission Date December 12, 2015
Published in Issue Year 2011 Volume: 9 Issue: 2

Cite

APA Ertem, M., Sevencan, F., Dorman, V., Ozcullu, N., et al. (2011). Pandemic (H1N1) influenza in Diyarbakir, 2009. Turkish Journal of Public Health, 9(2), 86-95.
AMA Ertem M, Sevencan F, Dorman V, Ozcullu N, Ormanli V, Kubat N, Albayrak N, Altas B. Pandemic (H1N1) influenza in Diyarbakir, 2009. TJPH. September 2011;9(2):86-95.
Chicago Ertem, Meliksah, Funda Sevencan, Vedat Dorman, Neval Ozcullu, Vahit Ormanli, Namik Kubat, Nurhan Albayrak, and Basak Altas. “Pandemic (H1N1) Influenza in Diyarbakir, 2009”. Turkish Journal of Public Health 9, no. 2 (September 2011): 86-95.
EndNote Ertem M, Sevencan F, Dorman V, Ozcullu N, Ormanli V, Kubat N, Albayrak N, Altas B (September 1, 2011) Pandemic (H1N1) influenza in Diyarbakir, 2009. Turkish Journal of Public Health 9 2 86–95.
IEEE M. Ertem, F. Sevencan, V. Dorman, N. Ozcullu, V. Ormanli, N. Kubat, N. Albayrak, and B. Altas, “Pandemic (H1N1) influenza in Diyarbakir, 2009”, TJPH, vol. 9, no. 2, pp. 86–95, 2011.
ISNAD Ertem, Meliksah et al. “Pandemic (H1N1) Influenza in Diyarbakir, 2009”. Turkish Journal of Public Health 9/2 (September 2011), 86-95.
JAMA Ertem M, Sevencan F, Dorman V, Ozcullu N, Ormanli V, Kubat N, Albayrak N, Altas B. Pandemic (H1N1) influenza in Diyarbakir, 2009. TJPH. 2011;9:86–95.
MLA Ertem, Meliksah et al. “Pandemic (H1N1) Influenza in Diyarbakir, 2009”. Turkish Journal of Public Health, vol. 9, no. 2, 2011, pp. 86-95.
Vancouver Ertem M, Sevencan F, Dorman V, Ozcullu N, Ormanli V, Kubat N, Albayrak N, Altas B. Pandemic (H1N1) influenza in Diyarbakir, 2009. TJPH. 2011;9(2):86-95.

13955                                        13956                                                             13958                                       13959                                        28911


TURKISH JOURNAL OF PUBLIC HEALTH - TURK J PUBLIC HEALTH. online-ISSN: 1304-1096 

Copyright holder Turkish Journal of Public Health. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International LicenseCreative Commons License